Document is current
Any future updates will be listed below
-
Authors
Wang, Zhixing
Wang, Xueyao
Chiu, Herng-Chia
Kong, Xiangrong
Li, Qingfeng
Ran, Xu
Liu, Yang
Liang, Hailun
Shi, Leiyu
- License Information
-
More Information
Article History
Received: 4 November 2024
Accepted: 5 February 2025
First Online: 18 February 2025
Declarations
:
: The study was approved by the Johns Hopkins Bloomberg School of Public Health Institutional Review Board Office, and the ID of the approval is FWA #00000287. The institutional review board approved that our study is a secondary data analysis involving the use of existing, de-identified data/specimens, including publicly available data. The research is conducted in accordance with the Declaration of Helsinki. The secondary data used in this study was collected by “Doctor-Patient Experience Research Base, National Health Commission”, which is a third-party data evaluation institution authorized by the National Health Commission of P. R. China. Written informed consent has been provided by the patients, or a parent or legal guardian if under the age of 18 years. The questionnaires of the survey are conducted anonymously and does not contain any personal identifier information or any privacy.
: The authors declare no competing interests.
